Key Features |
Product |
Transchymal-AD |
Transchymal-UC |
Transchymal-DP |
Transchymal-BM |
TransHSC |
TransBTE |
TransHNE |
Others |
Organism |
Homo sapiens, human |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Source |
Lipoaspirate |
√ |
|
|
|
|
|
|
√ |
Umblical Cord Matrix |
|
√ |
|
|
|
|
|
Dental Pulp |
|
|
√ |
|
|
|
|
Bone Marrow |
|
|
|
√ |
|
|
|
Cord Blood |
|
|
|
|
√ |
|
|
Breast Tumours |
|
|
|
|
|
√ |
|
Head & Neck Tumors |
|
|
|
|
|
|
√ |
Cell Type |
Mesencymal |
√ |
√ |
√ |
√ |
|
|
|
√ |
Hematopoiectic |
|
|
|
|
√ |
|
|
Primary Cancer Cells |
|
|
|
|
|
√ |
√ |
Morphology |
Spindle-shaped, fibroblast-like |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Growth Properties |
Adherent |
√ |
√ |
√ |
√ |
|
√ |
√ |
√ |
Suspended |
|
|
|
|
√ |
|
|
Biosafety Level |
1 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Disease |
Normal |
√ |
√ |
√ |
√ |
√ |
|
|
√ |
Malignant |
|
|
|
|
|
√ |
√ |
Age |
Lot Specific |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Gender |
Lot Specific |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Origin |
Indian |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
|
Non-Indian |
|
|
|
|
|
|
|
√ |
Product Format |
Frozen |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Storage Conditions |
-150 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Volume |
1ml |
|
|
|
|
|
|
|
√ |
1ml, 2ml & 5ml |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
|
Cells Per Vial |
1 x 106 viable cells |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Sterility Tests |
Bacteria and Yeast: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Mycoplasma: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Endotoxin: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
|
Viral Testing |
Hepatitis B: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Hepatitis C: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
HIV-1: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
HIV-2: Negative |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Viability |
≥ 70% when thawed from cryopreservation. |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Testing |
Karyotyping |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
|
CFU |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
|